Tag Archives: healthcare reform

ACA Rollout Raises Ante for Patient Access and Assistance

By Michael Christel. Amid the looming March 31 deadline for remaining uninsured and underinsured Americans to purchase health insurance mandated by the Affordable Care Act (6 million newly Medicaid-eligible individuals are expected to enroll), pharmaceutical manufacturers and other key players in this space are emphasizing the importance of enhancing access to medications for the now […]
Posted in Events, Regulatory | Also tagged , , , | Leave a comment

"Close Call" for American Rx Marketers on Medicare Part D

As the U.S. heads towards a public market place in which Medicare, Medicaid, CHIPs, VA, and now Obamacare will shortly comprise almost 70% of the American healthcare market, American Rx marketers recently endured a “close call” with the U.S. Department of Health and Human Services over the arbitrary deletion of dozens of key drugs from […]
Posted in Marketing, Op-Ed, Regulatory | Also tagged , , , | Leave a comment

2014: End of the Road for the American Rx Salesperson?

2014: End of the Road for the American Rx Salesperson? “The only thing you’ve got in this world is what you can sell.” Willy Loman Death of a Salesman During my years with two major U.S. pharmaceutical companies, some of the most interesting individuals I got to know were field salespersons.  Certainly one of my […]
Posted in Guest Blog, Op-Ed, Sales | Also tagged , , , , , | 17 Comments

Budget Options Will Reshape Healthcare

While the struggle continues in 2014 to provide effective and affordable coverage, administration and Congressional leaders will weigh a host of spending options important to coverage and delivery. Federal outlays for healthcare and health-related federal tax benefits exceed $1 trillion a year, according to the Congressional Budget Office (CBO). These and related spending on discretionary […]
Posted in Guest Blog, healthcare, Regulatory | Also tagged , , | Leave a comment

Obamacare and U.S. Pharma: Two Months In

U.S. Pharma in the Eye of the Obamacare Storm So, we’ve experienced two months of Obamacare.  How is the U.S. pharmaceutical industry doing with this new program?  I spent two weeks getting the opinions of several Rx representatives on their experience with Obamacare, as well as their thoughts on how it is impacting their marketing, […]
Posted in Guest Blog, healthcare, Op-Ed, Regulatory | Also tagged , , | 1 Comment
  • Categories

  • Meta